Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+1.42%
Changement Mensuel
-11.86%
Evolution sur 6 mois
-38.49%
Changement Annuel
+6.32%
Clôture Précédente
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Volume
58
Marchés
Actions des Marchés US
Soins de Santé
VSTM
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
Total assets
154.35 M
108.66 M
95.05 M
149.72 M
101.54 M
Total liabilities
39.08 M
21.1 M
47.66 M
71.19 M
130.43 M
Total equity
115.27 M
87.56 M
47.39 M
57.37 M
28.89 M
Total liabilities & shareholders' equities
154.35 M
108.66 M
95.05 M
149.72 M
101.54 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Nouvelles
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley riconferma il rating Buy per le azioni Verastem, mantiene target a $16
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem riporta 17,5 milioni di dollari di ricavi nel Q4 per trattamento oncologico
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
Il titolo di Revolution Medicines balza oltre il 20% su possibile acquisizione AbbVie
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Azioni Verastem stabili mentre Mizuho riconferma rating Outperform